305 related articles for article (PubMed ID: 14517846)
1. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.
Henn V; Slupsky JR; Gräfe M; Anagnostopoulos I; Förster R; Müller-Berghaus G; Kroczek RA
Nature; 1998 Feb; 391(6667):591-4. PubMed ID: 9468137
[TBL] [Abstract][Full Text] [Related]
3. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II modulates CD40 expression in vascular smooth muscle cells.
Souza HP; Frediani D; Cobra AL; Moretti AI; Jurado MC; Fernandes TR; Cardounel AJ; Zweier JL; Tostes RC
Clin Sci (Lond); 2009 Mar; 116(5):423-31. PubMed ID: 18785879
[TBL] [Abstract][Full Text] [Related]
6. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
Mach F; Schönbeck U; Sukhova GK; Atkinson E; Libby P
Nature; 1998 Jul; 394(6689):200-3. PubMed ID: 9671306
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine modulates the CD40/CD40L system.
Prontera C; Martelli N; Evangelista V; D'Urbano E; Manarini S; Recchiuti A; Dragani A; Passeri C; Davì G; Romano M
J Am Coll Cardiol; 2007 Jun; 49(22):2182-90. PubMed ID: 17543638
[TBL] [Abstract][Full Text] [Related]
8. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon.
Vowinkel T; Anthoni C; Wood KC; Stokes KY; Russell J; Gray L; Bharwani S; Senninger N; Alexander JS; Krieglstein CF; Grisham MB; Granger DN
Gastroenterology; 2007 Mar; 132(3):955-65. PubMed ID: 17324402
[TBL] [Abstract][Full Text] [Related]
9. Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ERalpha-mediated pathway.
Geraldes P; Gagnon S; Hadjadj S; Merhi Y; Sirois MG; Cloutier I; Tanguay JF
Cardiovasc Res; 2006 Aug; 71(3):566-73. PubMed ID: 16797503
[TBL] [Abstract][Full Text] [Related]
10. Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA.
Murakami K; Ma W; Fuleihan R; Pober JS
J Immunol; 1999 Sep; 163(5):2667-73. PubMed ID: 10453007
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
12. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.
Leroyer AS; Rautou PE; Silvestre JS; Castier Y; Lesèche G; Devue C; Duriez M; Brandes RP; Lutgens E; Tedgui A; Boulanger CM
J Am Coll Cardiol; 2008 Oct; 52(16):1302-11. PubMed ID: 18929241
[TBL] [Abstract][Full Text] [Related]
13. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
[TBL] [Abstract][Full Text] [Related]
14. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
Zirlik A; Bavendiek U; Libby P; MacFarlane L; Gerdes N; Jagielska J; Ernst S; Aikawa M; Nakano H; Tsitsikov E; Schönbeck U
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1101-7. PubMed ID: 17332487
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD40 and CD40 ligand in the human conjunctival epithelium.
Bourcier T; De Saint-Jean M; Brignole F; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):120-6. PubMed ID: 10634610
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligand: a novel target in the fight against cardiovascular disease.
Vishnevetsky D; Kiyanista VA; Gandhi PJ
Ann Pharmacother; 2004 Sep; 38(9):1500-8. PubMed ID: 15280513
[TBL] [Abstract][Full Text] [Related]
17. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.
Chen K; Huang J; Gong W; Zhang L; Yu P; Wang JM
Cell Mol Immunol; 2006 Jun; 3(3):163-9. PubMed ID: 16893496
[TBL] [Abstract][Full Text] [Related]
18. The CD40-CD40L system in cardiovascular disease.
Pamukcu B; Lip GY; Snezhitskiy V; Shantsila E
Ann Med; 2011 Aug; 43(5):331-40. PubMed ID: 21244217
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea.
Dyugovskaya L; Lavie P; Lavie L
Ann N Y Acad Sci; 2005 Jun; 1051():340-50. PubMed ID: 16126976
[TBL] [Abstract][Full Text] [Related]
20. CD40 and CD40L expression in the chicken embryo aorta: possible role in the endothelial-mesenchymal transdifferentiation process.
Arciniegas E; Becerra A; De Sanctis JB; Graterol A; Ramírez R
Anat Rec A Discov Mol Cell Evol Biol; 2003 Oct; 274(2):942-51. PubMed ID: 12973718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
